BIA Separations, a Sartorius company, develops and manufactures market-leading CIM® monolithic chromatographic columns for purification and analysis of large biomolecules, such as viruses, plasmids and mRNA, which are applied in cell and gene therapies. BIA's technology for manufacturing-scale purification is already used in production of the first commercialized advanced therapeutics; BIA also has a keen presence with novel drug candidates in the clinical pipeline. Expecting continued strong double-digit sales growth over the next few years, BIA earned sales revenue approx. 25 million Euros in 2020, contributing to Sartorius Bioprocess Solutions, part of the Sartorius Group.
Bio-Rad designs, manufactures, and distributes a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global team of more than 7,750 employees and serves more than 100,000 research and industry customers worldwide through the company’s global network of operations.
Every day, QIAGEN serves 500,000 customers globally, all seeking insights from the building blocks of life – DNA and RNA. Delivering Sample to Insight solutions for molecular testing, we enable scientists and clinicians to achieve breakthroughs in life sciences research, molecular diagnostics and drug development. We make improvements in life possible.
Founded in Stockholm in 2005, Vironova is a world leading partner to the global life science community in the development of novel therapies for tomorrow. By combining hardware and software solutions for advanced electron microscopy analysis, we support our partners through the whole value chain. From initial sample preparation to imaging and final analytical result, our dedicated team provide insightful and actionable data. We empower clients to make better-informed decisions, to create value and ensure safety for patients worldwide.
Beckman Coulter Inc. is one of the world’s leading manufacturers of measuring instruments and test assays in the field of life science and clinical diagnostics. For the discovery and development of new drugs, their production and medical diagnostics, scientists today need state-of-the-art tools and services to investigate complex biological systems and questions. Beckman Coulter Life Science supports our customers from the scientific, biotech and pharmaceutical sectors with a wide range of systems for the analysis of cells, proteins, particles and genomic materials. Whether pipetting robots or centrifuges, devices for cellular analysis or flow cytometry, antibodies for immunological assays or kits for genomic questions - all these solutions help today’s scientists to answer the challenging questions in the best possible way.
PROGEN helps scientists worldwide drive biopharmaceutical and diagnostic progress to provide high-quality and reliable treatments for patients. Our mission is to make new therapies safe and affordable and improve existing research processes.
We are more than just a manufacturer of antibodies, AAV gene therapy tools, density gradient media and phage display technologies: We strive to understand the needs of scientists to develop solutions to jointly address challenges in academic research, biotechnology and pharma.
When you make the invisible visible, the impossible is possible. Malvern Panalytical is the leading supplier of innovative material characterization solutions and services for pharmaceutical and gene therapy development. Our knowledge and expertise address the analytical challenges in this field, where biomolecular stability, activity, potency and purity are key product quality attributes. Our technologies provide rapid AAV titer, full:empty ratio, purity, detection and quantification of aggregates and fragments, and stability under thermal stress.
Gene Therapy holds great promise for neurological diseases. Researchers are delivering these molecular treatments to the brain with precision and efficiency, in both small and larger animal species. This translation has armed scientists with potentially lifesaving treatments for humans. Working with a seasoned research partner like Charles River provides access to years of experience with every step of the process.
SCIEX enables drug discovery and development for biologics and small molecule drugs, providing innovative LC-MS, LC-MS/MS and CE solutions that reduce complexity. Your therapeutics have variable molecular complexity and unique analytical needs. You need to make the best decisions quickly, based on data you can trust. SCIEX has a history of pioneering solutions that enable you to succeed in the face of escalating workloads and more complex biotherapeutic characterization demands. Our biologics characterization solutions make it possible to extend your analytical capability, increase lab throughput, streamline complex workflows and automate data processing – simplifying complex characterization processes and making them more accessible.
We’re giving shape to cell and gene therapy development every day, with 30+ years of biologics manufacturing and testing experience across all phases of clinical and commercial development. Our BioReliance® services offer the widest range of assays to fully characterize and analyze your therapy, giving you the confidence to deliver life-changing treatments to patients quickly and safely. MilliporeSigma, a life science leader, is a business of Merck KGaA, Darmstadt, Germany.
BioAnalytix works with leading biotherapeutic companies in the development and application of advanced analytics and data analysis of complex biologics, from candidate selection through regulatory package development. Applying state of the art mass spectrometry, biophysical analytics, and method development expertise, our team of PhDs provides precise data packages for specific project needs through all stages of biotherapeutic drug development, and we further offer our insights and understanding of CMC and regulatory requirements to support product development from IND through BLA.
Wyatt Technology is the recognized leader in light-scattering-based instrumentation and software for the biophysical characterization of nanotherapeutics, determining size and high-resolution size distributions, particle concentration, encapsulation efficiency, empty:full ratio, zeta potential and more. These tools include: multi-angle static light scattering coupled to size-based fractionation—SEC-MALS and AF4-MALS; high-throughput dynamic light scattering; and MP-PALS for automated electrophoretic mobility. Wyatt's training, service and support are widely considered the industry benchmark of excellence.
At their core, gene therapies are comprised of nucleic acids, proteins and lipids that need to be fully characterized, and for which precise chemistry, manufacturing and control (CMC) processes must be established to ensure their safety and efficacy. Waters offers a broad set of tools, solutions and expertise in biomolecular separations, mass analysis and biophysical characterization to support the development and commercialization of these new and exciting modalities.
Refeyn, the mass photometry pioneer, offers new capabilities to characterise the function, structural composition and dynamics of biomolecules. Refeyn instruments measure the mass of individual molecules directly, in solution without needing labels, quickly and simply revealing the true behaviour of molecules in near-native environments. The diverse applications include quantification of sample purity and homogeneity, biomolecular complex assembly and disassembly, the strength and kinetics of molecular interactions, and much more. Refeyn was spun out of Oxford University in 2018 to share mass photometry globally and its technology has seen rapid adoption across academia and industry, where it is transforming biomolecular characterisation.
Svar means 'answers' in Swedish. We are a life science company with proud Scandinavian roots and values, and a global perspective. We focus on helping deliver the answers needed in drug discovery and clinical diagnostics, and the impact this has on human lives.
Svar is in a unique position to offer assistance in any gene therapy project. We have robust platforms suited for all phases of drug development, as well as experience and knowledge from our diagnostic and bioanalytical services.
Mission Bio helps you unravel the inherent complexity of cancer and accelerate your advanced therapy development with its Tapestri Platform, powered by single-cell multi-omics. Discover how Tapestri enables accurate characterization of your cell and gene therapy candidates for safer and more effective therapeutic strategies. We partner with pharma and biopharma companies across advanced therapy development programs to implement proven single-cell multi-omics capabilities into discovery, translational, and clinical research efforts.
Boston Analytical is a cGMP compliant, FDA/DEA registered, ISO/IEC-17025:2005 certified analytical laboratory. We have the latest bioanalytical equipment and can help with peptide, protein, and oligonucleotide analysis and characterization under guidance documents such as ICH Q6B. Boston Analytical offers compendial methods as well as methods developed specific to your products. Boston Analytical offers compendial methods as well as methods developed specific to your products.
Our bespoke, purpose-built GLP / GCP / GMP laboratories have supported developers and manufacturers for over 20 years through the provision of advanced characterisation programs. We have worked on multiple studies involving cell or gene therapies, mRNA and plasmid DNA based products. Our facility has been designed to handle recombinant genomic materials for the purposes of research and compliant testing including specialist facilities for handling Class I and Class II Biological Agents.